0001808805-22-000101.txt : 20220928 0001808805-22-000101.hdr.sgml : 20220928 20220928160157 ACCESSION NUMBER: 0001808805-22-000101 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220926 FILED AS OF DATE: 20220928 DATE AS OF CHANGE: 20220928 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sankar Subramanian CENTRAL INDEX KEY: 0001856744 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39434 FILM NUMBER: 221275986 MAIL ADDRESS: STREET 1: C/O NAUTILUS BIOTECHNOLOGY, INC. STREET 2: 201 INDUSTRIAL RD. #310 CITY: SAN CARLOS STATE: CA ZIP: 94070 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nautilus Biotechnology, Inc. CENTRAL INDEX KEY: 0001808805 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2701 EASTLAKE AVE EAST CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: 206-333-2001 MAIL ADDRESS: STREET 1: 2701 EASTLAKE AVE EAST CITY: SEATTLE STATE: WA ZIP: 98102 FORMER COMPANY: FORMER CONFORMED NAME: ARYA Sciences Acquisition Corp III DATE OF NAME CHANGE: 20200408 4 1 wf-form4_166439528878324.xml FORM 4 X0306 4 2022-09-26 0 0001808805 Nautilus Biotechnology, Inc. NAUT 0001856744 Sankar Subramanian C/O NAUTILUS BIOTECHNOLOGY, INC. 2701 EASTLAKE AVENUE EAST SEATTLE WA 98102 0 1 0 0 Senior VP, Product Development Common Stock 2022-09-26 4 P 0 10000 2.025 A 86250 D Common Stock 2022-09-27 4 P 0 5000 2.0298 A 91250 D Represents the weighted average share price of an aggregate total of 10,000 shares purchased in the price range of $2.00 to $2.05 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Includes 1,250 shares of Common Stock acquired on June 1, 2022 through the Issuer's 2021 Employee Stock Purchase Plan. Represents the weighted average share price of an aggregate total of 5,000 shares purchased in the price range of $2.02 to $2.04 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. /s/ Matthew B. Murphy, as Attorney-in-Fact 2022-09-27